tradingkey.logo
tradingkey.logo
Search

CytomX Therapeutics Inc

CTMX
Add to Watchlist
3.220USD
+0.120+3.87%
Close 07-31 16:00ETQuotes delayed by 15 min
548.00MMarket Cap
LossP/E TTM

Institutional Confidence

Currency: USD Updated: 2026-07-31
Previous score
7.00
Change
0
The current institutional shareholding score of CytomX Therapeutics Inc is 7.00, ranking 80 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 78.87%, representing a quarter-over-quarter decrease of 19.41%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 9.71M shares, representing 3.62% of shares outstanding, with 33.21% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
Fidelity Management & Research Company LLC
20.19M
+54.43%
VR Adviser, LLC
15.56M
--
Longitude Capital Management Co., LLC
11.54M
--
Point72 Asset Management, L.P.
Star Investors
5.19M
+27.55%
Perceptive Advisors LLC
9.68M
--
Kynam Capital Management LP
8.97M
+145.88%
Commodore Capital LP
7.69M
--
State Street Investment Management (US)
5.14M
+697.07%
Baker Bros. Advisors LP
4.25M
--
1
2
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.